News & Updates

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025 byAudrey Abella

In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025